A detailed history of Eversept Partners, LP transactions in Alector, Inc. stock. As of the latest transaction made, Eversept Partners, LP holds 200,095 shares of ALEC stock, worth $340,161. This represents 0.04% of its overall portfolio holdings.

Number of Shares
200,095
Previous 332,756 39.87%
Holding current value
$340,161
Previous $1.55 Million 75.66%
% of portfolio
0.04%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$1.72 - $6.06 $228,176 - $803,925
-132,661 Reduced 39.87%
200,095 $378,000
Q3 2024

Nov 14, 2024

SELL
$4.34 - $6.58 $906,986 - $1.38 Million
-208,983 Reduced 38.58%
332,756 $1.55 Million
Q2 2024

Aug 14, 2024

BUY
$4.19 - $6.23 $23,329 - $34,688
5,568 Added 1.04%
541,739 $2.46 Million
Q1 2024

May 15, 2024

BUY
$5.69 - $8.08 $3.05 Million - $4.33 Million
536,171 New
536,171 $3.23 Million

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $140M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.